Junichiro Nasu

1.1k total citations · 1 hit paper
26 papers, 784 citations indexed

About

Junichiro Nasu is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Junichiro Nasu has authored 26 papers receiving a total of 784 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 12 papers in Oncology and 10 papers in Surgery. Recurrent topics in Junichiro Nasu's work include Gastric Cancer Management and Outcomes (13 papers), Metastasis and carcinoma case studies (7 papers) and Gastrointestinal Tumor Research and Treatment (7 papers). Junichiro Nasu is often cited by papers focused on Gastric Cancer Management and Outcomes (13 papers), Metastasis and carcinoma case studies (7 papers) and Gastrointestinal Tumor Research and Treatment (7 papers). Junichiro Nasu collaborates with scholars based in Japan, United States and United Kingdom. Junichiro Nasu's co-authors include Toshihiko Doi, Atsushi Ohtsu, Kuniaki Shirao, Kensei Yamaguchi, Haruhiko Fukuda, Narikazu Boku, Akira Sawaki, Hiroshi Saito, Wasaburo Koizumi and Hiroya Takiuchi and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and The Lancet Oncology.

In The Last Decade

Junichiro Nasu

26 papers receiving 771 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study

2009 472 citations Narikazu Boku, Seiichiro Yamamoto et al. The Lancet Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Junichiro Nasu Japan	10	599	348	327	310	64	26	784
Marcus Fernando Kodama Pertille Ramos Brazil	18	682 1.1×	343 1.0×	265 0.8×	380 1.2×	55 0.9×	97	900
Mao-Chih Hsieh Taiwan	16	453 0.8×	181 0.5×	216 0.7×	342 1.1×	39 0.6×	29	752
Pamela Dumas United States	8	516 0.9×	254 0.7×	246 0.8×	260 0.8×	80 1.3×	13	698
Norimasa Fukushima Japan	17	1.3k 2.2×	284 0.8×	807 2.5×	597 1.9×	33 0.5×	46	1.5k
Hideaki Nishidoi Japan	15	578 1.0×	168 0.5×	244 0.7×	370 1.2×	35 0.5×	55	715
Osamu Shiraishi Japan	17	613 1.0×	251 0.7×	90 0.3×	708 2.3×	38 0.6×	84	1.0k
Shun Yamamoto Japan	14	269 0.4×	323 0.9×	72 0.2×	338 1.1×	41 0.6×	79	604
Chang‐Ming Huang China	16	846 1.4×	237 0.7×	482 1.5×	479 1.5×	19 0.3×	66	1.0k
M.-H. Ryu South Korea	13	364 0.6×	295 0.8×	140 0.4×	196 0.6×	52 0.8×	27	578
H J Meyer Germany	7	447 0.7×	173 0.5×	181 0.6×	288 0.9×	27 0.4×	14	575

Countries citing papers authored by Junichiro Nasu

Since Specialization

Citations

This map shows the geographic impact of Junichiro Nasu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junichiro Nasu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junichiro Nasu more than expected).

Fields of papers citing papers by Junichiro Nasu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junichiro Nasu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junichiro Nasu. The network helps show where Junichiro Nasu may publish in the future.

Co-authorship network of co-authors of Junichiro Nasu

This figure shows the co-authorship network connecting the top 25 collaborators of Junichiro Nasu. A scholar is included among the top collaborators of Junichiro Nasu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junichiro Nasu. Junichiro Nasu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kanzaki, Hiromitsu, Takao Tsuzuki, Junichiro Nasu, et al.. (2023). Current prognostic factors of advanced gastric cancer patients treated with chemotherapy: real world data from a Japanese 12 institutions. Japanese Journal of Clinical Oncology. 53(10). 928–935. 3 indexed citations

Shiode, Junji, et al.. (2022). Correlation between hospital-onset and community-onset Clostridioides difficile infection incidence: Ward-level analysis following hospital relocation. American Journal of Infection Control. 50(11). 1240–1245. 1 indexed citations

Yasui, Hisateru, Atsushi Takeno, Hiroki Hara, et al.. (2022). Prospective analysis of the expression status of FGFR2 and HER2 in colorectal and gastric cancer populations: DS-Screen Study. International Journal of Colorectal Disease. 37(6). 1393–1402. 8 indexed citations

Shinozaki, Katsunori, Takeshi Yamada, Junichiro Nasu, et al.. (2020). A phase II study of FOLFOXIRI plus bevacizumab as initial chemotherapy for patients with untreated metastatic colorectal cancer: TRICC1414 (BeTRI). International Journal of Clinical Oncology. 26(2). 399–408. 3 indexed citations

Yamada, Takeshi, Tomohiro Nishina, Junichiro Nasu, et al.. (2020). A phase II study of FOLFOXIRI plus bevacizumab (Bmab) as initial chemotherapy for patients (pts) with untreated metastatic colorectal cancer (mCRC): TRICC1414 (Be TRI).. Journal of Clinical Oncology. 38(4_suppl). 134–134. 1 indexed citations

Fujii, Masakuni, Junichiro Nasu, Haruyuki Kawai, et al.. (2020). A rare case of immunotherapy-induced cholangitis and gastritis. Clinical Journal of Gastroenterology. 13(6). 1083–1090. 15 indexed citations

Matsueda, Katsunori, Hiromitsu Kanzaki, Kazuhiro Matsueda, et al.. (2019). The clinicopathological differences of sporadic non‐ampullary duodenal epithelial neoplasm depending on tumor location. Journal of Gastroenterology and Hepatology. 34(9). 1540–1544. 9 indexed citations

Fujii, Masakuni, Junji Shiode, Yuri Ito, et al.. (2018). Impact of Body Mass Index on Survival of Pancreatic Cancer Patients in Japan.. PubMed. 72(2). 129–135. 14 indexed citations

Saito, Hiroaki, Junji Shiode, Atsushi Yao, et al.. (2018). Whipple's Disease with Long-term Endoscopic Follow-up. Internal Medicine. 57(12). 1707–1713. 8 indexed citations

10.

Sakae, Hiroyuki, Hiromitsu Kanzaki, Junichiro Nasu, et al.. (2017). The characteristics and outcomes of small bowel adenocarcinoma: a multicentre retrospective observational study. British Journal of Cancer. 117(11). 1607–1613. 59 indexed citations

11.

Nagasaka, Takeshi, Hideyuki Mishima, Akira Sawaki, et al.. (2016). Protocol of a randomised phase III clinical trial of sequential capecitabine or 5-fluorouracil plus bevacizumab (Cape/5-FU-Bmab) to capecitabine or 5-fluorouracil plus oxaliplatin plus bevacizumab (CapeOX/mFOLFOX6-Bmab) versus combination CapeOX/mFOLFOX6-Bmab in advanced colorectal cancer: the C-cubed (C ³ ) study. BMJ Open. 6(6). e011454–e011454. 8 indexed citations

12.

Iwamuro, Masaya, Hiroyuki Okada, Katsuyoshi Takata, et al.. (2015). Magnified endoscopic features of duodenal follicular lymphoma and other whitish lesions.. PubMed. 69(1). 37–44. 9 indexed citations

13.

Muro, Shinichiro, Junichiro Nasu, Ryo Harada, et al.. (2014). Prompt resolution of hypoglycemia by hepatic transarterial embolization for malignant insulinoma with multiple liver metastases.. PubMed. 68(5). 303–6. 3 indexed citations

14.

Shirao, Kuniaki, Narikazu Boku, Yasuhide Yamada, et al.. (2013). Randomized Phase III Study of 5-Fluorouracil Continuous Infusion vs. Sequential Methotrexate and 5-Fluorouracil Therapy in Far Advanced Gastric Cancer with Peritoneal Metastasis (JCOG0106). Japanese Journal of Clinical Oncology. 43(10). 972–980. 85 indexed citations

15.

Kawahara, Yoshiro, Keisuke Hori, Ryuta Takenaka, et al.. (2013). Endoscopic submucosal dissection of esophageal cancer using the Mucosectom2 device: a feasibility study. Endoscopy. 45(11). 869–875. 15 indexed citations

16.

Kanzaki, Motoko, Jun Wada, Atsuko Nakatsuka, et al.. (2012). A Case of Type 2 Diabetes and Metastatic Liver Cancer Exhibiting Hypercholesterolemia with Abnormal Lipoproteins. Internal Medicine. 51(6). 619–623. 1 indexed citations

17.

Okada, Hiroyuki, Yoshiro Kawahara, Junichiro Nasu, et al.. (2012). A Prospective Analysis of Efficacy and Long-Term Outcome of Radiation Therapy for Gastric Mucosa-Associated Lymphoid Tissue Lymphoma. Digestion. 86(3). 179–186. 10 indexed citations

18.

Iwamuro, Masaya, Hiroyuki Okada, Katsuyoshi Takata, et al.. (2012). Primary Follicular Lymphoma of the Duodenum Relapsing 11 Years after Resection. Internal Medicine. 51(9). 1031–1035. 3 indexed citations

19.

Tsuzuki, Takao, Hiroyuki Okada, Yoshiro Kawahara, et al.. (2011). Usefulness and problems of endoscopic ultrasonography in prediction of the depth of tumor invasion in early gastric cancer.. PubMed. 65(2). 105–12. 31 indexed citations

20.

Boku, Narikazu, Seiichiro Yamamoto, Haruhiko Fukuda, et al.. (2009). Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study. The Lancet Oncology. 10(11). 1063–1069. 472 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact